Walter Ling Selected Research

Substance Withdrawal Syndrome (Withdrawal Symptoms)

3/2019	Treatment of opioid dependence with buprenorphine/naloxone sublingual tablets: A phase 3 randomized, double-blind, placebo-controlled trial.
7/2014	The relationship between primary prescription opioid and buprenorphine-naloxone induction outcomes in a prescription opioid dependent sample.
9/2011	Participant characteristics and buprenorphine dose.
1/2011	Selective review and commentary on emerging pharmacotherapies for opioid addiction.
10/2010	Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial.
1/2010	Provision of ancillary medications during buprenorphine detoxification does not improve treatment outcomes.
1/2010	Association of race and ethnicity with withdrawal symptoms, attrition, opioid use, and side-effects during buprenorphine therapy.
4/2009	Treatment for amphetamine withdrawal.
1/2009	Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence.
9/2008	A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Walter Ling Research Topics

Disease

57	Opioid-Related Disorders (Opiate Addiction) 03/2023 - 09/2002
21	Substance-Related Disorders (Drug Abuse) 01/2023 - 01/2002
15	Pain (Aches) 01/2019 - 08/2001
12	Cocaine-Related Disorders (Cocaine Addiction) 06/2022 - 05/2002
11	Substance Withdrawal Syndrome (Withdrawal Symptoms) 03/2019 - 01/2008
5	Hyperalgesia 01/2019 - 09/2008
5	Alcoholism (Alcohol Abuse) 01/2011 - 01/2002
3	Chronic Pain 07/2017 - 12/2011
2	Respiratory Insufficiency (Respiratory Failure) 01/2019 - 02/2006
2	Acute Pain 01/2019 - 08/2001
2	Infections 12/2017 - 02/2013
2	Hallucinations (Hallucination) 01/2011 - 01/2009
2	Cognitive Dysfunction 01/2011 - 01/2002
2	Psychotic Disorders (Schizoaffective Disorder) 01/2009 - 07/2002
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2021
1	Anorexia 01/2021
1	Hyperhidrosis 01/2021
1	Tremor (Tremors) 01/2021
1	Nasopharyngitis 03/2019
1	Poisoning 01/2019
1	Injection Site Reaction 01/2019
1	Constipation 01/2019
1	Headache (Headaches) 01/2019
1	Nausea 01/2019
1	Pruritus (Itching) 01/2019
1	Disease Progression 01/2017
1	Mental Disorders (Mental Disorder) 03/2015
1	Gambling (Pathological Gambling) 08/2013
1	Tobacco Use Disorder (Nicotine Dependence) 08/2013
1	Hepatitis B 02/2013
1	Hepatitis C 02/2013
1	Chemical and Drug Induced Liver Injury 02/2013
1	Hypersensitivity (Allergy) 01/2011
1	Neuralgia (Stump Neuralgia) 06/2010
1	Diarrhea 01/2010
1	Paranoid Disorders (Paranoia) 01/2009
1	Hypotension (Low Blood Pressure) 09/2008
1	Weight Loss (Weight Reduction) 07/2007

Drug/Important Bio-Agent (IBA)

42	Buprenorphine (Subutex)FDA LinkGeneric 03/2023 - 04/2003
40	Opioid Analgesics (Opioids)IBA 03/2019 - 04/2003
21	Naloxone Drug Combination Buprenorphine FDA Link 06/2022 - 01/2004
16	Methadone (Dolophine)FDA LinkGeneric 01/2019 - 08/2001
10	Naltrexone (ReVia)FDA LinkGeneric 01/2021 - 01/2002
9	Opiate AlkaloidsIBA 07/2015 - 01/2002
7	TabletsIBA 03/2019 - 09/2003
7	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2011 - 01/2002
6	trans-crotonin (CTN)IBA 01/2018 - 01/2004
6	Cocaine (Cocaine HCl)IBA 01/2016 - 12/2003
6	Heroin (Diamorphine)IBA 07/2013 - 03/2010
4	Naloxone (Narcan)FDA LinkGeneric 06/2012 - 09/2003
4	Clonidine (ST 155)FDA LinkGeneric 01/2009 - 08/2005
3	Morphine (MS Contin)FDA LinkGeneric 01/2019 - 08/2001
3	Narcotic Antagonists (Opioid Antagonists)IBA 12/2013 - 04/2011
3	Amphetamine (Amfetamine)FDA LinkGeneric 01/2011 - 01/2009
3	lofexidineIBA 01/2011 - 01/2008
2	TeaIBA 01/2023 - 01/2019
2	Bupropion (Wellbutrin)FDA LinkGeneric 01/2021 - 01/2008
2	Analgesics (Analgesic Drugs)IBA 12/2015 - 10/2003
2	mu Opioid Receptors (mu Opioid Receptor)IBA 12/2013 - 04/2003
2	N-nitrosoiminodiacetic acidIBA 06/2010 - 01/2009
2	Dopamine (Intropin)FDA LinkGeneric 01/2008 - 07/2007
1	SublocadeIBA 03/2023
1	Genetic Markers (Genetic Marker)IBA 06/2022
1	preproenkephalinIBA 06/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 03/2019
1	norbuprenorphineIBA 01/2019
1	XR 300IBA 01/2019
1	insulin receptor-related receptor (IRR)IBA 07/2017
1	vivitrol FDA Link 01/2016
1	Opioid Receptors (Opioid Receptor)IBA 09/2013
1	Indicators and Reagents (Reagents)IBA 08/2013
1	Caffeine (No Doz)FDA LinkGeneric 08/2013
1	Transaminases (Aminotransferases)IBA 02/2013
1	Illicit Drugs (Recreational Drugs)IBA 02/2013
1	Delayed-Action PreparationsIBA 04/2011
1	AmphetaminesIBA 01/2011
1	Gabapentin (Neurontin)FDA LinkGeneric 06/2010
1	Mirtazapine (Rexer)FDA LinkGeneric 04/2009
1	amineptin (amineptine)IBA 04/2009
1	Chlorpromazine (Thorazine)FDA Link 01/2009
1	Dopamine AntagonistsIBA 01/2009
1	Olanzapine (Zyprexa)FDA Link 01/2009
1	Antipsychotic Agents (Antipsychotics)IBA 01/2009
1	Thioridazine (Mellaril)FDA LinkGeneric 01/2009
1	Haloperidol (Haldol)FDA LinkGeneric 01/2009
1	Plant ExtractsIBA 01/2009
1	Disulfiram (Antabuse)FDA Link 01/2009
1	Mescaline (Peyote)IBA 01/2009
1	daidzinIBA 01/2009
1	Aldehyde DehydrogenaseIBA 01/2009
1	Dextromethorphan (Racemethorphan)FDA LinkGeneric 09/2008
1	N-Methylaspartate (NMDA)IBA 09/2008
1	diethylaminosulfur trifluorideIBA 06/2008
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2008

Therapy/Procedure

16	Drug Therapy (Chemotherapy) 09/2020 - 05/2002
7	Therapeutics 06/2022 - 10/2003
7	Injections 01/2016 - 04/2011
1	Art Therapy 12/2017
1	Opiate Substitution Treatment 04/2012
1	Traditional Medicine (Folk Remedies) 01/2009